Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank100
3Y CAGR+3.1%
5Y CAGR+8.3%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+3.1%/yr
vs +63.0%/yr prior
5Y CAGR
+8.3%/yr
Recent deceleration
Acceleration
-59.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.64B | +1768.5% |
| 2024 | $248.50M | -94.3% |
| 2023 | $4.38B | +3.5% |
| 2022 | $4.23B | +55.0% |
| 2021 | $2.73B | -12.4% |
| 2020 | $3.12B | +123.4% |
| 2019 | $1.39B | +132.4% |
| 2018 | $600.24M | +3925.9% |
| 2017 | $-15.69M | +76.7% |
| 2016 | $-67.37M | - |